MAPK3 and breast cancer: Upon stimulation of MDA-231BO2 cells, a RANK+ human bone-seeking breast cancer cell line, RANKL activates specific downstream signaling pathways, namely JNK (c-Jun N-terminal kinases) and ERK1/2 (extracellular signal regulated kinase), leading to an invasive phenotype.